Edwards Lifesciences (EW) Buildings (2023 - 2025)

Edwards Lifesciences' Buildings history runs 3 years deep, the most recent figure standing at $1.4 billion for Q4 2025.

• On a quarterly basis, Buildings rose 3.99% year-over-year to $1.4 billion in Q4 2025; TTM through Dec 2025 was $1.4 billion, a 3.99% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 3.99% from the prior year.
• Buildings improved to $1.4 billion in Q4 2025 per EW's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Buildings topped out at $1.4 billion in Q4 2025 and bottomed at $1.2 billion in Q4 2023.
• The 3-year median for Buildings is $1.3 billion (2024), against an average of $1.3 billion.
• Across the five-year window, Buildings grew 12.68% in 2024 and increased 3.99% in 2025, its largest moves.
• Year by year, Buildings stood at $1.2 billion in 2023, then increased by 12.68% to $1.3 billion in 2024, then climbed by 3.99% to $1.4 billion in 2025.
• Per Business Quant, the three latest EW Buildings figures stand at $1.4 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.2 billion (Q4 2023).